Virtual Reality for Neglect Diagnostics
KMS-Neglect
1 other identifier
observational
27
1 country
1
Brief Summary
Compared to the classical "paper and pencil"-tests, testing patients in our virtual reality setup might have a higher sensitivity and specificity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started May 2011
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2011
CompletedFirst Submitted
Initial submission to the registry
July 8, 2011
CompletedFirst Posted
Study publicly available on registry
July 21, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2012
CompletedNovember 29, 2018
November 1, 2018
1.2 years
July 8, 2011
November 28, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Feasibility
Feasibility of the use of a virtual reality setup in the diagnostics of neglect
within the first 2 years after stroke
Secondary Outcomes (2)
Sensitivity and Specificity
within the first 2 years after stroke
mri (functional (resting state) and structural imaging
within the first 2 years after stroke
Study Arms (3)
Patients with Neglect
Patients with Hemianopsia
Healthy age-matched controls
Interventions
testing for neglect in a virtual reality setup
testing for neglect with the classical paper-and-pencil tests
structural and functional (resting state) imaging
Eligibility Criteria
Patients with acute (\< 2 wks after stroke), subacute (2 wks- 3 months after stroke)or chronic (3- 24 months after stroke)stroke with neglect or hemianopsia. Healthy, age-matched controls.
You may qualify if:
- age ≥18 and \<80 years
- first stroke
- neglect symptoms
- no hemianopsia symptoms
- consent given by the patient
- age ≥18 and \<80 years
- first stroke
- no neglect symptoms
- hemianopsia symptoms
- consent given by the patient
- age ≥18 and \<80 years
- no neurological deficits
- informed consent
You may not qualify if:
- language comprehension deficits
- motor deficits of the upper extremities
- cognitive impairments (MMSE \<20 or SKT \>15 or DEMTEC \>12)
- depression
- seizure disorders
- claustrophobia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Charite University, Berlin, Germanylead
- Median Klinik Kladowcollaborator
- Freie Universität Berlincollaborator
- Berlin Center for Advanced Neuroimagingcollaborator
- Humboldt-Universität zu Berlincollaborator
- NeuroCure Clinical Research Center, Charite, Berlincollaborator
Study Sites (1)
Charité University Medicine
Berlin, 10117, Germany
Related Publications (1)
Ulm L, Wohlrapp D, Meinzer M, Steinicke R, Schatz A, Denzler P, Klehmet J, Dohle C, Niedeggen M, Meisel A, Winter Y. A circle-monitor for computerised assessment of visual neglect in peripersonal space. PLoS One. 2013 Dec 12;8(12):e82892. doi: 10.1371/journal.pone.0082892. eCollection 2013.
PMID: 24349387RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Andreas Meisel, MD
Charite University (Center for Stroke Research Berlin CSB & NeuroCure Clinical Research Center NCRC)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Prof. Dr. Andreas Meisel
Study Record Dates
First Submitted
July 8, 2011
First Posted
July 21, 2011
Study Start
May 1, 2011
Primary Completion
July 1, 2012
Study Completion
July 1, 2012
Last Updated
November 29, 2018
Record last verified: 2018-11